The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

8 articles for A Gagnon


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery, design, and synthesis of indole-based EZH2 inhibitors.EBI
Constellation Pharmaceuticals
Multi-parameter optimization of aza-follow-ups to BI 207524, a thumb pocket 1 HCV NS5B polymerase inhibitor. Part 2: Impact of lipophilicity on promiscuity and in vivo toxicity.EBI
Boehringer Ingelheim (Canada)
Discovery and Optimization of Tetramethylpiperidinyl Benzamides as Inhibitors of EZH2.EBI
Constellation Pharmaceuticals
Synthesis of NVS-BPTF-1 and evaluation of its biological activity.EBI
University of Montreal
Synthesis of NSC 106084 and NSC 14778 and evaluation of their DNMT inhibitory activity.EBI
University of Montreal
Inhibition of HIV-1 capsid assembly: optimization of the antiviral potency by site selective modifications at N1, C2 and C16 of a 5-(5-furan-2-yl-pyrazol-1-yl)-1H-benzimidazole scaffold.EBI
Boehringer Ingelheim (Canada)
Thiotetrazole alkynylacetanilides as potent and bioavailable non-nucleoside inhibitors of the HIV-1 wild type and K103N/Y181C double mutant reverse transcriptases.EBI
Boehringer Ingelheim (Canada)
Heterocyclic compounds and methods for their useBDB
Novartis